Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA GLENMARK PHARMA SANOFI INDIA/
GLENMARK PHARMA
 
P/E (TTM) x 29.8 -30.8 - View Chart
P/BV x 14.8 2.8 529.0% View Chart
Dividend Yield % 7.3 0.3 2,741.1%  

Financials

 SANOFI INDIA   GLENMARK PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
GLENMARK PHARMA
Mar-23
SANOFI INDIA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs7,939487 1,629.7%   
Low Rs5,454349 1,563.2%   
Sales per share (Unadj.) Rs1,202.8460.4 261.3%  
Earnings per share (Unadj.) Rs269.513.4 2,014.8%  
Cash flow per share (Unadj.) Rs287.735.0 821.0%  
Dividends per share (Unadj.) Rs570.002.50 22,800.0%  
Avg Dividend yield %8.50.6 1,423.3%  
Book value per share (Unadj.) Rs527.0335.1 157.2%  
Shares outstanding (eoy) m23.03282.17 8.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.60.9 613.1%   
Avg P/E ratio x24.931.3 79.5%  
P/CF ratio (eoy) x23.311.9 195.1%  
Price / Book Value ratio x12.71.2 1,018.8%  
Dividend payout %211.518.7 1,131.7%   
Avg Mkt Cap Rs m154,224117,953 130.8%   
No. of employees `000NANA-   
Total wages/salary Rs m4,05927,810 14.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,701129,901 21.3%  
Other income Rs m7303,168 23.0%   
Total revenues Rs m28,431133,069 21.4%   
Gross profit Rs m8,34915,125 55.2%  
Depreciation Rs m4196,113 6.9%   
Interest Rs m173,496 0.5%   
Profit before tax Rs m8,6438,685 99.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4374,911 49.6%   
Profit after tax Rs m6,2063,774 164.4%  
Gross profit margin %30.111.6 258.9%  
Effective tax rate %28.256.5 49.9%   
Net profit margin %22.42.9 771.1%  
BALANCE SHEET DATA
Current assets Rs m36,12198,737 36.6%   
Current liabilities Rs m27,42550,455 54.4%   
Net working cap to sales %31.437.2 84.5%  
Current ratio x1.32.0 67.3%  
Inventory Days Days1177 1,742.2%  
Debtors Days Days17115 14.8%  
Net fixed assets Rs m12,14876,920 15.8%   
Share capital Rs m230282 81.5%   
"Free" reserves Rs m11,90694,281 12.6%   
Net worth Rs m12,13694,563 12.8%   
Long term debt Rs m038,521 0.0%   
Total assets Rs m48,279175,658 27.5%  
Interest coverage x509.43.5 14,620.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.7 77.6%   
Return on assets %12.94.1 311.4%  
Return on equity %51.14.0 1,281.3%  
Return on capital %71.49.2 779.7%  
Exports to sales %14.10-   
Imports to sales %14.60-   
Exports (fob) Rs m3,904NA-   
Imports (cif) Rs m4,037NA-   
Fx inflow Rs m3,90446,464 8.4%   
Fx outflow Rs m4,03712,712 31.8%   
Net fx Rs m-13333,751 -0.4%   
CASH FLOW
From Operations Rs m3,9876,254 63.8%  
From Investments Rs m6,509-5,285 -123.2%  
From Financial Activity Rs m-15,827-775 2,043.4%  
Net Cashflow Rs m-5,331325 -1,640.3%  

Share Holding

Indian Promoters % 0.0 46.7 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 27.1 34.7 78.3%  
FIIs % 6.3 23.7 26.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 53.4 74.2%  
Shareholders   62,870 209,931 29.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Sanofi India vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs Glenmark Pharma Share Price Performance

Period Sanofi India Glenmark Pharma S&P BSE HEALTHCARE
1-Day 0.75% 1.37% 0.88%
1-Month -14.93% 8.88% -4.09%
1-Year 36.65% 111.03% 59.00%
3-Year CAGR -0.77% 27.24% 18.97%
5-Year CAGR 6.86% 7.86% 19.20%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 570.0 per share. This amounted to a Dividend Payout ratio of 211.5%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets reversed the trend as the session progressed and ended the day higher.